Shrydus Industries Ltd
Incorporation in 1983, Shrydus Industries Ltd is in the business of healthcare, pharma, real estate and green energy[1]
- Market Cap ₹ 11.2 Cr.
- Current Price ₹ 3.49
- High / Low ₹ 9.74 / 2.85
- Stock P/E
- Book Value ₹ 15.8
- Dividend Yield 0.00 %
- ROCE 24.5 %
- ROE 29.2 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.22 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Promoter holding is low: 25.9%
- Promoter holding has decreased over last 3 years: -13.8%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|
| 0.34 | 0.53 | 0.45 | 9.45 | 39.81 | 0.20 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| 0.57 | 0.61 | 0.53 | 8.93 | 31.53 | 3.49 | |
| Financing Profit | -0.23 | -0.08 | -0.08 | 0.52 | 8.27 | -3.29 |
| Financing Margin % | -67.65% | -15.09% | -17.78% | 5.50% | 20.77% | -1,645.00% |
| 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Depreciation | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.26 | -0.10 | -0.12 | 0.52 | 8.27 | -3.28 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| -0.26 | -0.10 | -0.12 | 0.52 | 8.27 | -2.79 | |
| EPS in Rs | 0.16 | 2.58 | -0.87 | |||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -127% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 18% |
| 3 Years: | -51% |
| 1 Year: | -59% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 29% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 6.35 | 6.35 | 6.35 | 12.01 | 32.02 | 32.02 |
| Reserves | -2.60 | -2.69 | -2.81 | -6.05 | 18.56 | 18.47 |
| Borrowing | 3.42 | 3.42 | 3.42 | 10.91 | 0.02 | 0.02 |
| 0.23 | 0.25 | 0.27 | 0.02 | 0.02 | 0.02 | |
| Total Liabilities | 7.40 | 7.33 | 7.23 | 16.89 | 50.62 | 50.53 |
| 0.52 | 0.49 | 0.45 | 0.00 | 0.01 | 0.01 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.91 | 2.27 | 2.27 | 0.00 | 0.00 | 0.00 |
| 3.97 | 4.57 | 4.51 | 16.89 | 50.61 | 50.52 | |
| Total Assets | 7.40 | 7.33 | 7.23 | 16.89 | 50.62 | 50.53 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| -13.46 | -25.48 | ||||
| 0.00 | -0.01 | ||||
| 12.58 | 25.46 | ||||
| Net Cash Flow | -0.88 | -0.03 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| ROE % | -6.93% | -2.70% | -3.33% | 8.72% | 29.25% |
Documents
Announcements
- Unaudited Standalone And Consolidated Financial Result For The Quarter And Nine Months Ended December 31, 2025 1d
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th February, 2026
1d - Unaudited standalone and consolidated Q3 and nine-month results ended Dec 31, 2025; limited review.
-
Board Meeting Intimation for Consider And Approve The Unaudited Financial Result For The Quarter Ended December 31, 2025
6 Feb - Board meeting on 13 Feb 2026 to approve unaudited results for quarter ended 31 Dec 2025.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7 Jan - Certificate under SEBI Reg 74(5) for quarter ended 31 Dec 2025 from RTA Skyline.
- Closure of Trading Window 26 Dec 2025
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
SIL (formerly VCK Capital Market Services Ltd) is an integrated and diversified corporate group which has ventured into multiple businesses. It was into Agricultural Commodities and Healthcare products business and is now diversifying in Pharmaceutical Formulation Plant, Astra Lifecare Pvt. Ltd., and Green Energy sector